Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias (Q35750919)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 2007
edit
Language Label Description Also known as
English
Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias
scientific article published on April 2007

    Statements

    Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias (English)
    Ivana Gojo
    Anchalee Jiemjit
    William D Figg
    Sandra Rollins
    Michael L Tidwell
    Jacqueline Greer
    Eun Joo Chung
    Min-Jung Lee
    Steven D Gore
    Edward A Sausville
    James Zwiebel
    Judith E Karp
    2781-2790

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit